The state of irreversible electroporation in interventional oncology

Seminars in Interventional Radiology

Volumn 31, Issue 2, 2014, Pages 111-117

  Silk, Mikhail ^a   Tahour, David ^a   Srimathveeravalli, Govindarajan ^a   Solomon, Stephen B ^a   Thornton, Raymond H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

ablation; interventional oncology; interventional radiology; irreversible electroporation; kidney; liver; lung; pancreas

Indexed keywords

ABLATION THERAPY; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROPORATION; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; INTERVENTIONAL RADIOLOGY; IRREVERSIBLE ELECTROPORATION; IRREVERSIBLE ELECTROPORATION DEVICE; KIDNEY CARCINOMA; LIVER TUMOR; LUNG SMALL CELL CANCER; MEDICAL EDUCATION; NEEDLE ELECTRODE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY; THERMAL ABLATION; THERMAL INJURY; THYROID CARCINOMA;

EID: 84901300578     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0034-1373785     Document Type: Article

References (42)

1. Coster H. G. A quantitative analysis of the voltage-current relationships of fixed charge membranes and the associated property of punch-through Biophys J: 1965; 5 5 669 686
2. Davalos R. V., Mir I. L., Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng: 2005; 33 2 223 231 (Pubitemid 40496051)
3. Breton M., Mir L. M. Microsecond and nanosecond electric pulses in cancer treatments. Bioelectromagnetics: 2012; 33 2 106 123
4. Charpentier K. P., Wolf F., Noble L., Winn B., Resnick M., Dupuy D. E. Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford): 2011; 13 3 168 173
5. Schoellnast H., Monette S., Ezell P. C., et al. Acute and subacute effects of irreversible electroporation on nerves: experimental study in a pig model. Radiology: 2011; 260 2 421 427
6. Schoellnast H., Monette S., Ezell P. C., et al. The delayed effects of irreversible electroporation ablation on nerves. Eur Radiol: 2013; 23 2 375 380
7. Silk M. T., Wimmer T., Lee K. S., et al. Percutaneous ablation of peribiliary tumors with irreversible electroporation. J Vasc Interv Radiol: 2014; 25 1 112 118
8. Neal R. E. II, Smith R. L., Kavnoudias H., et al. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage. Cardiovasc Intervent Radiol: 2013; 36 6 1638 1645
9. Onik G., Mikus P., Rubinsky B. Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat: 2007; 6 4 295 300 (Pubitemid 47340121)
10. Mandel Y., Laufer S., Belkin M., Rubinsky B., Pe'er J., Frenkel S. Irreversible electroporation of human primary uveal melanoma in enucleated eyes. PLoS ONE: 2013; 8 9 e71789
11. Garcia P. A., Rossmeisl J. H. Jr, Davalos R. V. Electrical conductivity changes during irreversible electroporation treatment of brain cancer. Conf Proc IEEE Eng Med Biol Soc: 2011; 2011 739 742
12. Hjouj M., Last D., Guez D., et al. MRI study on reversible and irreversible electroporation induced blood brain barrier disruption. PLoS ONE: 2012; 7 8 e42817
13. Neal R. E. II, Rossmeisl J. H. Jr, D'Alfonso V., et al. In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment. Ann Biomed Eng: 2013; 42 3 475 487
14. Gervais D. A., Goldberg S. N., Brown D. B., Soulen M. C., Millward S. F., Rajan D. K. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol: 2009; 20 (7, Suppl): S342 S347
15. Thomson K. R., Cheung W., Ellis S. J., et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol: 2011; 22 5 611 621
16. Kingham T. P., Karkar A. M., D'Angelica M. I., et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg: 2012; 215 3 379 387
17. Cannon R., Ellis S., Hayes D., Narayanan G., Martin R. C. II. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol: 2013; 107 5 544 549
18. Goldberg S. N., Mallery S., Gazelle G. S., Brugge W. R. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc: 1999; 50 3 392 401 (Pubitemid 29418828)
19. Pezzilli R., Serra C., Ricci C., et al. Radiofrequency ablation for advanced ductal pancreatic carcinoma: is this approach beneficial for our patients? A systematic review. Pancreas: 2011; 40 1 163 165
20. Bower M., Sherwood L., Li Y., Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol: 2011; 104 1 22 28
21. Narayanan G., Hosein P. J., Arora G., et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol: 2012; 23 12 1613 1621
22. Martin R. C. II, McFarland K., Ellis S., Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol: 2013; 20 03 S443 S449
23. Zagoria R. J., Pettus J. A., Rogers M., Werle D. M., Childs D., Leyendecker J. R. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology: 2011; 77 6 1393 1397
24. Pettus J. A., Werle D. M., Saunders W., et al. Percutaneous radiofrequency ablation does not affect glomerular filtration rate. J Endourol: 2010; 24 10 1687 1691
25. Park S. Y., Park B. K., Kim C. K., et al. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery. Acta Radiol: 2011; 52 6 680 685
26. Pech M., Janitzky A., Wendler J. J., et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol: 2011; 34 1 132 138
27. Zhu J. C., Yan T. D., Glenn D., Morris D. L. Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg: 2009; 87 4 1023 1028
28. Usman M., Moore W., Talati R., Watkins K., Bilfinger T. V. Irreversible electroporation of lung neoplasm: a case series. Med Sci Monit: 2012; 18 6 CS43 CS47
29. Silk M., Wimmer T., Getrajdman G., et al. Safety of irreversible electroporation (IRE) treatment for metastatic disease in humans. J Vasc Interv Radiol: 2013; 24 S21 S22
30. Srimathveeravalli G., Wimmer T., Silk M., et al. Treatment planning considerations for IRE in the lung: placement of needle electrodes is critical. J Vasc Interv Radiol: 2013; 24 S22
31. Ball C., Thomson K. R., Kavnoudias H. Irreversible electroporation: a new challenge in out of operating theater anesthesia. Anesth Analg: 2010; 110 5 1305 1309
32. Silk M. T., Lee H. M., Wimmer T., et al. Evolution of the ablation zone following irreversible electroporation of liver tumors on computed tomography and possible predictors of recurrence. Paper Presented at: World Conference of Interventional Oncology; May 17, 2013; New York, NY
33. Au J. T., Kingham T. P., Jun K., et al. Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography. Surgery: 2013; 153 6 787 793
34. Schmidt C. R., Shires P., Mootoo M. Real-time ultrasound imaging of irreversible electroporation in a porcine liver model adequately characterizes the zone of cellular necrosis. HPB (Oxford): 2012; 14 2 98 102
35. Guo Y., Zhang Y., Nijm G. M., et al. Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones. Radiology: 2011; 258 2 461 468
36. Rubinsky B., Onik G., Mikus P. Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat: 2007; 6 1 37 48 (Pubitemid 46389347)
37. Neal R. E. II, Singh R., Hatcher H. C., Kock N. D., Torti S. V., Davalos R. V. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat: 2010; 123 1 295 301
38. Qin Z., Jiang J., Long G., Lindgren B., Bischof J. C. Irreversible electroporation: an in vivo study with dorsal skin fold chamber. Ann Biomed Eng: 2013; 41 3 619 629
39. Ben-David E., Ahmed M., Faroja M., et al. Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties. Radiology: 2013; 269 3 738 747
40. Davalos R. V., Rubinsky B. Temperature considerations during irreversible electroporation. Int J Heat Mass Transfer: 2008; 51 5617 5622
41. Olweny E. O., Kapur P., Tan Y. K., Park S. K., Adibi M., Cadeddu J. A. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney. Urology: 2013; 81 3 679 684
42. Faroja M., Ahmed M., Appelbaum L., et al. Irreversible electroporation ablation: is all the damage nonthermal? Radiology: 2013; 266 2 462 470